Ira Duarte
Finanzdirektor/CFO bei HERON THERAPEUTICS, INC.
Vermögen: 826 743 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Ira Duarte
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 18 | |
| Public Company | Agricultural Commodities/Milling | 16 | |
| Public Company | Biotechnology | 15 | |
| Subsidiary | Pharmaceuticals: Major | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ira Duarte
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chairman | |
| SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Forcepoint LLC
 Forcepoint LLC Packaged SoftwareTechnology Services Forcepoint LLC provides unified web, email, and data security solutions. It offers data security consulting, security intelligence consulting, cyber security intelligence, training and technical certification, implementation packages, and government certification services. The company was founded in 1994 and is headquartered in Austin, TX. | Packaged Software | General Counsel | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Arbor Pharmaceuticals LLC
 Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Chairman | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| RECEPTOS INC | Pharmaceuticals: Major | General Counsel | |
Vensun Pharmaceuticals, Inc.
 Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vitruvias Therapeutics, Inc.
 Vitruvias Therapeutics, Inc. Medical/Nursing ServicesHealth Services Vitruvias Therapeutics LLC researches and develops generic drugs. The company was founded by Carl L. Whatley and Bryce Harvey and is headquartered in Auburn, AL. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
C.W. Obel A/S
 C.W. Obel A/S Financial ConglomeratesFinance C.W. Obel A/S provides investment services to industrial companies. The firm's financial assets are located in collaboration with independent financial advisor used by banks and pension companies. The company was founded by Christen Winther Obel in 1787 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Purdue University | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
| University of Kentucky | College/University | Doctorate Degree Undergraduate Degree | |
| Western Michigan University | College/University | Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| University of Copenhagen | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | General Counsel | |
Broadfin Capital LLC
 Broadfin Capital LLC Investment ManagersFinance Broadfin Capital LLC (Broadfin) is an independent hedge fund manager headquartered in New York City. The firm was founded by Kevin Kotler in 2005. Through the funds they advise, the firm may provide investment management services to individuals, investment companies, pooled investment vehicles, pension and profit sharing plans, trusts, estates, governmental plans, endowments, foundations, charitable organizations, corporations, insurance companies, limited partnerships, commingled investment trusts, and other entities. | Investment Managers | Chief Executive Officer Analyst-Equity | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member General Counsel Chief Tech/Sci/R&D Officer Director/Board Member | |
DYSIS Medical Ltd.
 DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Medical Specialties | Director/Board Member | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Corporate Officer/Principal | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| University of San Diego School of Law | College/University | Graduate Degree | |
Zyla Life Sciences US, Inc.
 Zyla Life Sciences US, Inc. Pharmaceuticals: MajorHealth Technology Zyla Life Sciences US, Inc. develops and manufactures pharmaceutical products. The company is headquartered in Wayne, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Defender Pharmaceuticals, Inc. | Chief Executive Officer Chief Executive Officer | ||
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Biotechnology | Chief Executive Officer | |
Abzu ApS
 Abzu ApS Packaged SoftwareTechnology Services Abzu ApS provides technology services. It offers Abzu AI platform. The firm specializes in data, deep and machine learning, AI platform, cell based model, predictive problems and artificial general intelligence. The company was founded by Casper Skern Wilstrup in January 2018 and is headquartered in Copenhagen, Denmark. | Packaged Software | Director/Board Member | |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
JW Asset Management LLC /Private Equity/
 JW Asset Management LLC /Private Equity/ Investment ManagersFinance JW Asset Management LLC (JW Asset Management) is a private equity subsidiary of JW Asset Management LLC founded in 2003 by Jason Wild. The firm is headquartered in Armonk, New York. | Investment Managers | President | |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
| LEXEO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| RANI THERAPEUTICS HOLDINGS, INC. | Biotechnology | General Counsel | |
ValSource LLC
 ValSource LLC Pharmaceuticals: MajorHealth Technology ValSource LLC provides consulting and advisory services to the pharmaceutical, advanced therapy medicinal products, biologics, and medical device industries. The private company is based in Downingtown, PA. The company's services aim to ensure the success and speed-to-market of client projects. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 44 |
| Dänemark | 6 |
| Frankreich | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 11 |
| Finance | 4 |
| Technology Services | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 173 |
| Corporate Officer/Principal | 111 |
| Independent Dir/Board Member | 62 |
| President | 48 |
| Chief Executive Officer | 46 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Mette Agger | 30 |
| Paul Wotton | 27 |
| Thomas Dyrberg | 24 |
| Edward Schutter | 24 |
| James McNulty | 23 |
| Michael Heffernan | 23 |
| Robert Radie | 18 |
| David Szekeres | 18 |
| Craig Collard | 18 |
| Craig Johnson | 17 |
| George Ng | 17 |
| Adam Morgan | 15 |
| Kevin Kotler | 14 |
| Charles Bramlage | 13 |
| Alastair Stuart McEwan | 12 |
- Börse
- Insiders
- Ira Duarte
- Unternehmensverbindungen
